HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$5.11
Day range
$5.09 - $5.50
Year range
$3.79 - $14.60
Market cap
268.05M USD
Avg Volume
898.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.25M | 8.20% |
Net income | 7.38M | 189.76% |
Net profit margin | — | — |
Earnings per share | -0.14 | — |
EBITDA | -7.88M | -3.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 92.16M | 258.44% |
Total assets | 95.90M | 207.22% |
Total liabilities | 21.23M | -15.88% |
Total equity | 74.68M | — |
Shares outstanding | 50.10M | — |
Price to book | 3.36 | — |
Return on assets | -20.05% | — |
Return on capital | -24.58% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 7.38M | 189.76% |
Cash from operations | -8.62M | -2.11% |
Cash from investing | -3.00K | 57.14% |
Cash from financing | -1.87M | -49.00% |
Net change in cash | -10.49M | -8.13% |
Free cash flow | -21.26M | -283.31% |
About
Founded
2003
Headquarters
Website
Employees
38
